Chemoinformaics analysis of 11,12-Dehydroursolactone-Acetate
| Molecular Weight | 386.488 | nRot | 3 |
| Heavy Atom Molecular Weight | 356.248 | nRig | 24 |
| Exact Molecular Weight | 386.209 | nRing | 4 |
| Solubility: LogS | -3.922 | nHRing | 0 |
| Solubility: LogP | 2.825 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 62.4238 |
| nHD | 0 | BPOL | 35.3042 |
| QED | 0.548 |
| Synth | 4.421 |
| Natural Product Likeliness | 2.163 |
| NR-PPAR-gamma | 0.751 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.952 |
| Pgp-sub | 0.002 |
| HIA | 0.035 |
| CACO-2 | -4.859 |
| MDCK | 0.0000273 |
| BBB | 0.667 |
| PPB | 0.487759 |
| VDSS | 0.65 |
| FU | 0.560143 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.191 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.474 |
| CYP2c9-inh | 0.14 |
| CYP2c9-sub | 0.146 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.253 |
| CYP3a4-inh | 0.397 |
| CYP3a4-sub | 0.317 |
| CL | 11.508 |
| T12 | 0.78 |
| hERG | 0.007 |
| Ames | 0.051 |
| ROA | 0.9 |
| SkinSen | 0.032 |
| Carcinogencity | 0.857 |
| EI | 0.019 |
| Respiratory | 0.794 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.56135 |